Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaparoBell vs Myrept in Kidney Transplant Maintenance
NCT05193565Phase 4Active, not recruiting
- Sponsor
- Chong Kun Dang Holdings
- Start
- Nov 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of RaparoBell in kidney transplantation, sponsored by Chong Kun Dang Holdings. Started Nov 2021; status: active, not recruiting.
02
Drugs
RaparoBell
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT05193565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193565.